TREA

79300811 - HHHBIO

Follow

Information

  • Trademark
  • 79300811
  • Serial Number
    79300811
  • Registration Number
    6399124
  • Filing Date
    July 10, 2020
    6 years ago
  • Registration Date
    June 29, 2021
    5 years ago
  • Transaction Date
    November 23, 2021
    4 years ago
  • Status Date
    June 29, 2021
    5 years ago
  • Published for Opposition Date
    April 13, 2021
    5 years ago
  • Location Date
    June 29, 2021
    5 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    KETCHUM, BRENDAN J
  • Attorney Docket Number
    I2420.82862U
    Attorney Name
    Paul G. Johnson
    Law Office Assigned Location Code
    N70
  • Owners
Information
Mark Drawing Code
5000
Mark Identification
HHHBIO
Case File Statements
  • CC0000: The color(s) green and red is/are claimed as a feature of the mark.
  • DM0000: The mark consists of a stylized word "HHHBio" which consists of the three overlapped "H"s connected to "B" in green and "i" and "o" in red.
  • GS0051: Drugs for medical purposes, namely, drugs for the treatment of oncological and metabolic diseases and disorders; medicines for human purposes, namely, medicine for the treatment of infectious diseases; medicines for human purposes, namely, medicine for the treatment of viral diseases and disorders; medicines for human purposes, namely, medicine for the treatment of respiratory diseases and disorders; therapeutic drugs and agents, namely, therapeutic drugs for the treatment of immune system related diseases and disorders; pharmaceutical preparations for preventing and treating obesity; vaccines; human vaccine preparations; pharmaceutical agents affecting metabolism; protein for medical purposes, namely, protein arrays for diagnosing cancer; protein for medical purposes, namely, protein arrays for diagnosing allergies; peptide for medical purposes, namely, synthetic peptides for the treatment of immune system related diseases and disorders; synthetic protein for the treatment of diabetes; synthetic protein for the treatment of oncological and metabolic diseases and disorders; synthetic peptide for the treatment of obesity; synthetic peptide for the treatment of viral diseases and disorders; pharmaceutical preparations containing peptides as the active ingredients, namely, pharmaceutical preparations for the treatment of neurological diseases and disorders
  • GS0421: Research relating to pharmaceuticals, namely, pharmaceutical research services; medicine research, namely, research and development of medicines; medical analysis services of peptide for the treatment of people; research for medical products, namely medical research; chemical research; biological research; laboratory research in the field of pharmaceuticals; clinical studies of medicines, namely, conducting clinical trials for others; operation of medical laboratory, namely, medical laboratory services; scientific research for medical purposes; research and development of peptide for medical purposes; research of biology; research and development of peptide for scientific or laboratory purposes; drug discovery services; research and development of technology for biotechnology; development of pharmaceutical preparations and medicines
Case File Event Statements
  • 11/23/2021 - 4 years ago
    25 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 10/28/2021 - 4 years ago
    24 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 10/28/2021 - 4 years ago
    23 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 9/29/2021 - 4 years ago
    22 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 6/29/2021 - 5 years ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/13/2021 - 5 years ago
    20 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 4/13/2021 - 5 years ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/13/2021 - 5 years ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/24/2021 - 5 years ago
    17 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 3/24/2021 - 5 years ago
    16 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 3/24/2021 - 5 years ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/11/2021 - 5 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/10/2021 - 5 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/9/2021 - 5 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/9/2021 - 5 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/1/2021 - 5 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/5/2021 - 5 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/5/2021 - 5 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 1/20/2021 - 5 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 1/19/2021 - 5 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/16/2021 - 5 years ago
    5 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 1/12/2021 - 5 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/12/2021 - 5 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 1/11/2021 - 5 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 12/24/2020 - 5 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR